APO RESEARCH · REPORT
Fosfomycin Trometamol
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Product & engineering
Understand the product.
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Selected research
Industry Growth & Trends
Global Fosfomycin Trometamol Industry Growth and Trends Forecast to 2032
Market perspective
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
Read the full market overview
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
Report Scope
This report provides a structured, data-driven view of the global Fosfomycin Trometamol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fosfomycin Trometamol market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fosfomycin Trometamol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fosfomycin Trometamol.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fosfomycin Trometamol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fosfomycin Trometamol Market by Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
Fosfomycin Trometamol Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Fosfomycin Trometamol Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
Fosfomycin Trometamol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Trometamol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Trometamol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Trometamol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fosfomycin Trometamol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fosfomycin Trometamol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fosfomycin Tromethamine Granules
- Fosfomycin Tromethamine Powder
Applications
- Common Urinary Tract Infection
- Postoperative Urinary Tract Infection
- Preoperative Prevention of Urinary Tract Infection
- Others
Companies covered
- Zambon
- Northesat Pharm
- Hunan Huana Pharmaceuticals
- Xunda Pharma
- FarmaSino Pharmaceutical
- Guilin Hwasun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fosfomycin Trometamol Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fosfomycin Trometamol Sales Estimates and Forecasts (2021-2032)
- 1.3 Fosfomycin Trometamol Market by Type
- 1.3.1 Fosfomycin Tromethamine Granules
- 1.3.2 Fosfomycin Tromethamine Powder
- 1.4 Global Fosfomycin Trometamol Market Size by Type
- 1.4.1 Global Fosfomycin Trometamol Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fosfomycin Trometamol Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fosfomycin Trometamol Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fosfomycin Trometamol Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fosfomycin Trometamol Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fosfomycin Trometamol Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fosfomycin Trometamol Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fosfomycin Trometamol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fosfomycin Trometamol Industry Trends
- 2.2 Fosfomycin Trometamol Industry Drivers
- 2.3 Fosfomycin Trometamol Industry Opportunities and Challenges
- 2.4 Fosfomycin Trometamol Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fosfomycin Trometamol Revenue (2021-2026)
- 3.2 Global Top Players by Fosfomycin Trometamol Sales (2021-2026)
- 3.3 Global Top Players by Fosfomycin Trometamol Price (2021-2026)
- 3.4 Global Fosfomycin Trometamol Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fosfomycin Trometamol Major Company Production Sites & Headquarters
- 3.6 Global Fosfomycin Trometamol Company, Product Type & Application
- 3.7 Global Fosfomycin Trometamol Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fosfomycin Trometamol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fosfomycin Trometamol Players Market Share by Revenue in 2025
- 3.8.3 2025 Fosfomycin Trometamol Tier 1, Tier 2, and Tier 3
4 Fosfomycin Trometamol Regional Status and Outlook
- 4.1 Global Fosfomycin Trometamol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fosfomycin Trometamol Historic Market Size by Region
- 4.2.1 Global Fosfomycin Trometamol Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fosfomycin Trometamol Sales in Value by Region (2021-2026)
- 4.2.3 Global Fosfomycin Trometamol Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fosfomycin Trometamol Forecasted Market Size by Region
- 4.3.1 Global Fosfomycin Trometamol Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fosfomycin Trometamol Sales in Value by Region (2027-2032)
- 4.3.3 Global Fosfomycin Trometamol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fosfomycin Trometamol by Application
- 5.1 Fosfomycin Trometamol Market by Application
- 5.1.1 Common Urinary Tract Infection
- 5.1.2 Postoperative Urinary Tract Infection
- 5.1.3 Preoperative Prevention of Urinary Tract Infection
- 5.1.4 Others
- 5.2 Global Fosfomycin Trometamol Market Size by Application
- 5.2.1 Global Fosfomycin Trometamol Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fosfomycin Trometamol Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fosfomycin Trometamol Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fosfomycin Trometamol Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fosfomycin Trometamol Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fosfomycin Trometamol Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fosfomycin Trometamol Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fosfomycin Trometamol Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zambon
- 6.1.1 Zambon Company Information
- 6.1.2 Zambon Business Overview
- 6.1.3 Zambon Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zambon Fosfomycin Trometamol Product Portfolio
- 6.1.5 Zambon Recent Developments
- 6.2 Northesat Pharm
- 6.2.1 Northesat Pharm Company Information
- 6.2.2 Northesat Pharm Business Overview
- 6.2.3 Northesat Pharm Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Northesat Pharm Fosfomycin Trometamol Product Portfolio
- 6.2.5 Northesat Pharm Recent Developments
- 6.3 Hunan Huana Pharmaceuticals
- 6.3.1 Hunan Huana Pharmaceuticals Company Information
- 6.3.2 Hunan Huana Pharmaceuticals Business Overview
- 6.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Product Portfolio
- 6.3.5 Hunan Huana Pharmaceuticals Recent Developments
- 6.4 Xunda Pharma
- 6.4.1 Xunda Pharma Company Information
- 6.4.2 Xunda Pharma Business Overview
- 6.4.3 Xunda Pharma Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Xunda Pharma Fosfomycin Trometamol Product Portfolio
- 6.4.5 Xunda Pharma Recent Developments
- 6.5 FarmaSino Pharmaceutical
- 6.5.1 FarmaSino Pharmaceutical Company Information
- 6.5.2 FarmaSino Pharmaceutical Business Overview
- 6.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 FarmaSino Pharmaceutical Fosfomycin Trometamol Product Portfolio
- 6.5.5 FarmaSino Pharmaceutical Recent Developments
- 6.6 Guilin Hwasun
- 6.6.1 Guilin Hwasun Company Information
- 6.6.2 Guilin Hwasun Business Overview
- 6.6.3 Guilin Hwasun Fosfomycin Trometamol Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Guilin Hwasun Fosfomycin Trometamol Product Portfolio
- 6.6.5 Guilin Hwasun Recent Developments
7 North America by Country
- 7.1 North America Fosfomycin Trometamol Sales by Country
- 7.1.1 North America Fosfomycin Trometamol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fosfomycin Trometamol Sales by Country (2021-2026)
- 7.1.3 North America Fosfomycin Trometamol Sales Forecast by Country (2027-2032)
- 7.2 North America Fosfomycin Trometamol Market Size by Country
- 7.2.1 North America Fosfomycin Trometamol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fosfomycin Trometamol Market Size by Country (2021-2026)
- 7.2.3 North America Fosfomycin Trometamol Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fosfomycin Trometamol Sales by Country
- 8.1.1 Europe Fosfomycin Trometamol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fosfomycin Trometamol Sales by Country (2021-2026)
- 8.1.3 Europe Fosfomycin Trometamol Sales Forecast by Country (2027-2032)
- 8.2 Europe Fosfomycin Trometamol Market Size by Country
- 8.2.1 Europe Fosfomycin Trometamol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fosfomycin Trometamol Market Size by Country (2021-2026)
- 8.2.3 Europe Fosfomycin Trometamol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fosfomycin Trometamol Sales by Country
- 9.1.1 Asia-Pacific Fosfomycin Trometamol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fosfomycin Trometamol Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fosfomycin Trometamol Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fosfomycin Trometamol Market Size by Country
- 9.2.1 Asia-Pacific Fosfomycin Trometamol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fosfomycin Trometamol Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fosfomycin Trometamol Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fosfomycin Trometamol Sales by Country
- 10.1.1 South America Fosfomycin Trometamol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fosfomycin Trometamol Sales by Country (2021-2026)
- 10.1.3 South America Fosfomycin Trometamol Sales Forecast by Country (2027-2032)
- 10.2 South America Fosfomycin Trometamol Market Size by Country
- 10.2.1 South America Fosfomycin Trometamol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fosfomycin Trometamol Market Size by Country (2021-2026)
- 10.2.3 South America Fosfomycin Trometamol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fosfomycin Trometamol Sales by Country
- 11.1.1 Middle East and Africa Fosfomycin Trometamol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fosfomycin Trometamol Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fosfomycin Trometamol Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fosfomycin Trometamol Market Size by Country
- 11.2.1 Middle East and Africa Fosfomycin Trometamol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fosfomycin Trometamol Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fosfomycin Trometamol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fosfomycin Trometamol Value Chain Analysis
- 12.1.1 Fosfomycin Trometamol Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fosfomycin Trometamol Production Mode & Process
- 12.2 Fosfomycin Trometamol Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fosfomycin Trometamol Distributors
- 12.2.3 Fosfomycin Trometamol Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst